You just read:

Now available in Saskatchewan, (Pr)SEEBRI* BREEZHALER*, a long-term once-daily maintenance treatment for chronic obstructive pulmonary disease (COPD)

News provided by

Novartis Pharmaceuticals Canada Inc.

Sep 23, 2013, 10:00 ET